08.05.2014 Views

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Renal<br />

dysfunction<br />

Vision–<br />

Yellow<br />

Disturbed<br />

vision<br />

x x x x x x x<br />

x<br />

x<br />

x x x x x x x x<br />

Hypotension x x x x x<br />

Skin<br />

eruption<br />

SJ syndrome<br />

/TEN<br />

Toxic<br />

erythem<br />

a<br />

x x x x x x x x<br />

191982 x<br />

Urticaria x x x x x<br />

Pruritus x x x x x x<br />

Oral lesions x x<br />

Anosmia<br />

Jaundice x x<br />

Psychosis x x x x x<br />

CNS Facial<br />

parathesia<br />

Peripheral<br />

neuritis<br />

Encephalopathy<br />

Neuromuscular<br />

block<br />

x x x x x x x x x<br />

x<br />

191971 x<br />

191952 x x<br />

x x x x x x x x<br />

Histamine release = Headache, flushing and fall in blood pressure<br />

Injection site reaction = pain, soreness, induration and lipodystrophy<br />

Intrathecal injection reactions = headache, nausea and vomiting, nystagmus, slow respiration,<br />

retention of urine, delirium, loss of weight and meningeal irritation<br />

Deafness = deafness and tinnitus<br />

Vestibular effects = Vertigo, dizziness, giddiness, ataxia and cochlear toxicity<br />

Neuromuscular blockade = impaired vision, respiratory paralysis (1961) and muscular weakness<br />

(1965)<br />

Skin eruptions = urticaria, angioneurotic oedema, purpura, erythroderma; roseola, follicular, maculopapular,<br />

scarlatiniform, morbilliform and bullous exanthemas

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!